Total Payments
$20,354
2024 Payments
$2,633
Companies
68
Transactions
1,415
Medicare Patients
8,062
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$19,967 (98.1%)
Travel$326.47 (1.6%)
Education$60.85 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,967 | 1,409 | 98.1% |
| Travel and Lodging | $326.47 | 2 | 1.6% |
| Education | $60.85 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,282 | 131 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $2,158 | 314 | $0 (2024) |
| Abbott Laboratories | $1,772 | 106 | $0 (2024) |
| Nevro Corp. | $913.96 | 79 | $0 (2022) |
| Relievant Medsystems, Inc. | $906.91 | 22 | $0 (2023) |
| ABBVIE INC. | $841.59 | 46 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $731.16 | 39 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $624.22 | 76 | $0 (2021) |
| Egalet US Inc | $614.29 | 80 | $0 (2018) |
| Medtronic, Inc. | $608.24 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,633 | 188 | Collegium Pharmaceutical, Inc. ($460.61) |
| 2023 | $3,301 | 203 | Collegium Pharmaceutical, Inc. ($541.95) |
| 2022 | $3,182 | 222 | Abbott Laboratories ($762.47) |
| 2021 | $3,434 | 259 | BOSTON SCIENTIFIC CORPORATION ($515.80) |
| 2020 | $1,628 | 110 | Nevro Corp. ($339.81) |
| 2019 | $2,241 | 134 | Zyla Life Sciences ($277.22) |
| 2018 | $2,238 | 182 | Egalet US Inc ($311.80) |
| 2017 | $1,699 | 117 | Egalet US Inc ($302.49) |
All Payment Transactions
1,415 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Pain Management | ||||||
| 12/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.99 | General |
| Category: Opioid Analgesic | ||||||
| 12/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $33.37 | General |
| 12/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $5.31 | General |
| Category: Opioid Analgesic | ||||||
| 12/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $2.19 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.78 | General |
| 12/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $10.84 | General |
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $5.40 | General |
| Category: Opioid Analgesic | ||||||
| 11/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $4.72 | General |
| Category: Opioid Analgesic | ||||||
| 11/21/2024 | Fidia Pharma USA Inc. | HYM/HYN (Device) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $2.56 | General |
| Category: Opioid Analgesic | ||||||
| 11/13/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $4.98 | General |
| Category: Opioid Analgesic | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Analgesic | ||||||
| 11/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $5.89 | General |
| Category: Opioid Analgesic | ||||||
| 11/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $5.42 | General |
| Category: Opioid Analgesic | ||||||
| 11/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $1.31 | General |
| Category: Opioid Analgesic | ||||||
| 11/04/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $101.37 | General |
| Category: Pain Management | ||||||
| 10/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,793 | 6,701 | $1.7M | $363,383 |
| 2022 | 31 | 1,817 | 7,863 | $1.7M | $366,279 |
| 2021 | 34 | 2,310 | 6,917 | $2.5M | $536,507 |
| 2020 | 33 | 2,142 | 4,952 | $2.6M | $421,312 |
Total Patients
8,062
Total Services
26,433
Medicare Billing
$1.7M
Procedure Codes
140
All Medicare Procedures & Services
140 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 258 | 464 | $208,800 | $51,002 | 24.4% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 128 | 173 | $169,540 | $42,209 | 24.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 57 | 63 | $172,480 | $37,511 | 21.7% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2023 | 31 | 2,520 | $252,000 | $33,396 | 13.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 84 | 119 | $128,050 | $26,787 | 20.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 55 | 60 | $70,850 | $20,049 | 28.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 96 | 175 | $75,250 | $19,470 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 110 | 110 | $63,800 | $16,238 | 25.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 64 | 78 | $69,600 | $14,663 | 21.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 84 | 119 | $65,010 | $13,858 | 21.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 41 | 54 | $53,460 | $13,223 | 24.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 18 | 23 | $54,250 | $11,968 | 22.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 94 | 171 | $50,370 | $11,883 | 23.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 32 | 47 | $54,670 | $11,162 | 20.4% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 15 | 20 | $22,720 | $6,553 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 80 | $25,600 | $6,114 | 23.9% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 32 | 47 | $26,950 | $5,706 | 21.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 19 | 20 | $18,200 | $4,557 | 25.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 24 | 37 | $14,500 | $3,303 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $11,700 | $3,025 | 25.9% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 15 | 24 | $8,880 | $2,368 | 26.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 18 | 19 | $7,790 | $2,067 | 26.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 27 | 29 | $6,380 | $1,503 | 23.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 104 | 224 | $4,480 | $1,340 | 29.9% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2023 | 34 | 41 | $9,310 | $1,280 | 13.7% |
About Dr. Daniel Kohane, M.D
Dr. Daniel Kohane, M.D is a Interventional Pain Medicine healthcare provider based in Babylon, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1235399734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kohane, M.D has received a total of $20,354 in payments from pharmaceutical and medical device companies, with $2,633 received in 2024. These payments were reported across 1,415 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($19,967).
As a Medicare-enrolled provider, Kohane has provided services to 8,062 Medicare beneficiaries, totaling 26,433 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 140 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine
- Location Babylon, NY
- Active Since 06/10/2008
- Last Updated 06/18/2021
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1235399734
Products in Payments
- XTAMPZA (Drug) $1,353
- Intracept (Device) $958.85
- Belbuca (Drug) $602.58
- INTELLIS (Device) $579.23
- BELBUCA (Drug) $560.42
- Senza Spinal Cord Stimulation System (Device) $544.01
- ZTLido (Drug) $537.39
- Horizant (Drug) $488.70
- AXIUM (Device) $450.66
- PENNSAID (Drug) $441.58
- ARTISAN (Device) $440.60
- Proclaim Family of SCS IPGs (Device) $411.66
- mild Device Kit (Device) $404.08
- PROCLAIM (Device) $394.59
- UBRELVY (Drug) $384.00
- SPRIX (Drug) $377.08
- Omnia (Device) $369.95
- Nalu Neurostimulation System (Device) $366.12
- Morphabond ER (Drug) $340.31
- QULIPTA (Drug) $330.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.